Learn How to Capitalize on the Industry's Shifting Patient Engagement Model---Register Now for PM360's “The New Healthcare Trifecta” Webcast

Share Article

Webcast will be held on January 20th at 3 PM EST

The patient engagement model is dramatically shifting. Historically, the relationship between drug developers and patients is often viewed in commercial terms. But recently, pharma, patients and advocacy groups are talking about uniting to harness patient and advocacy insights and build lasting relationships.

On January 20th at 3PM EST, PM360 will host an exclusive webcast, sponsored by Takeda and The Snow Companies, which will probe this dynamic alliance and delve into the issues that have ignited the broadening dialogue and discuss the growing importance of collaborating from the onset of development to post-approval.

To register for free, go to https://events.essrx.com/PM360/717F2.nsf/Register.

Why You Should Attend:

  •     Hear both perspectives (industry and patients) about the best ways to work together.
  •     Learn new strategies to get patients involved throughout the product pipeline.
  •     Discover the importance of building lasting relationships with patients and advocacy.

Who Should Attend:
Individuals with responsibilities in:

  •     Brand Management
  •     Healthcare Marketing
  •     Patient Advocacy & Public Affairs
  •     Advocacy Organizations
  •     Clinical Research

Panel of Experts:
Thomas P. Sellers, MPA, Sr. Director, Patient Advocacy & Corporate Philanthropy at Takeda Oncology
Tom is a cancer survivor who joined Millennium in 2011 and currently manages relationships with the patient community and programs to ensure that patients have information and access to treatments.

Ronny Mosston, Vice President of Patient Advocacy & Public Affairs at OvaScience
Ronny currently works for a company focused on the discovery, development and commercialization of new fertility treatments. She has consulted biotech organizations to develop innovative, compliant and cross-functional Patient/Advocacy strategies in all phases of the drug pipeline.

Brenda Snow, Founder & CEO of The Snow Companies
Ms. Snow is living with multiple sclerosis and has made it her life’s mission to connect people living with chronic conditions to their peers and leaders in the life science industry. As the Founder and CEO of the healthcare communication agency, The Snow Companies, she is making this vision a reality.

Lona Vincent, MPH, Senior Associate Director of Research Partnerships at The Michael J. Fox Foundation for Parkinson's Research
Lona leads the Foundation’s clinical interventional research initiatives, including payer engagement, regulatory strategy, and the data science program on wearable devices. Lona stays closely linked to the Parkinson’s research community to develop an agenda for accelerating research and development to ensure that priorities reflect and best serve the needs of patients.

Moderator:
Paul Kidwell, a Boston-based, independent public relations consultant providing public relations support for biopharmaceutical companies in the areas of media relations, patient advocacy and social media will host the event. He has more than 25 years of corporate and agency public relations experience.

Register now to hear their insights on how pharma, patients and advocacy can all work together to improve care.

###

PM360 is the premier source for information that product managers and pharma and medical device marketing professionals need to succeed in the complex, ever-changing healthcare environment. PM360 offers invaluable perspective on important industry issues through a full-circle combination of how-to information and thoughtful career insights.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Elaine Andrecovich
Makovsky
+1 212-508-9675
Email >